Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes The Manila Times
Covered in this story
Analyst targets on Vaxcyte Inc
- BTIG: $73.8 → $89 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $PCVX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Vaxcyte Inc →Also covered by 1 other outlet
Dalsna Finance is currently tracking 7 stories mentioning Vaxcyte Inc, the earliest published 5 Oct 2026.
Summary aggregated from The Manila Times's public RSS feed. The full reporting belongs to The Manila Times — please read it on their site.